Related Funds
| Fund Name | Location |
| BizMark | Alberta, Calgary, Canada |
| Cluster Capital | - |
| Iconica Partners | - |
| Infinity Blockchain Holdings | - |
| Iowa Startup Accelerator | Cedar Rapids, Iowa, United States |
| SMU Investimentos | Brazil, São Paulo, Sao Paulo |
| Strategic Legacy Investment Group | California, Los Angeles, United States |
| Yamato Holdings | Japan, Tokyo |
| Zhejiang Orient Group Industry & Finance Investment | China, Hangzhou, Zhejiang |
| Zhongji Financial | Beijing, Beijing, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Kriya Therapeutics | $270M | 16 May 2022 | Palo Alto, California, United States | ||
Kriya Therapeutics | $100M | 14 Jul 2021 | Palo Alto, California, United States | ||
Kriya Therapeutics | $80M | 12 May 2020 | Palo Alto, California, United States | ||
Kriya Therapeutics | 01 Oct 2019 | Palo Alto, California, United States |
– Kriya closed a $100m Series B financing to support its mission of transforming the design, development and manufacturing of gene therapies.
– The financing was led by Patient Square Capital with participation from new investors Woodline Partners LP, CAM Capital, Hongkou, Alumni Ventures and others.
– All existing institutional investors also participated in this round, including QVT, Dexcel Pharma, Foresite Capital, Bluebird Ventures, Transhuman Capital, Narya Capital, Amplo and JDRF T1D Fund.
– Proceeds from the financing will be used to further develop Kriya’s core technology platforms, expand its therapeutic pipeline and advance its current programs in metabolic disease, ophthalmology and oncology.
– Jim Momtazee, Managing Partner of Patient Square Capital, will join Kriya’s Board of Directors.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Kriya Therapeutics | $270M | 16 May 2022 | Palo Alto, California, United States | ||
Kriya Therapeutics | $100M | 14 Jul 2021 | Palo Alto, California, United States | ||
Kriya Therapeutics | $80M | 12 May 2020 | Palo Alto, California, United States | ||
Kriya Therapeutics | 01 Oct 2019 | Palo Alto, California, United States |
